North America Pharmacokinetics and Pharmacodynamics Market Overview
North America pharmacokinetics and pharmacodynamics market size was USD 0.6 billion in 2022. The North America pharmacokinetics and pharmacodynamics market industry is projected to grow from USD 0.7 billion in 2023 to USD 1.31 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.09% during the forecast period (2023 - 2032).The factors contributing to the growth of the market include the increasing prevalence of chronic diseases, advancements in technology and analytical techniques, and strong healthcare infrastructure. Additionally, the growing popularity of personalized medicine will provide growth opportunities for the market in the future. However, the shortage of skilled and experienced professionals might hamper the market's growth in the forecast period.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Pharmacokinetics and Pharmacodynamics Market Trends
- RISING INCIDENCE OF CHRONIC DISEASES
The rising incidence of chronic diseases, including cardiovascular disorders, diabetes, and cancer, serves as a pivotal driver for the North America pharmacokinetics and pharmacodynamics market. As these conditions become more prevalent, there is a growing need for advanced therapeutic interventions that can provide personalized and effective treatment. Pharmacokinetics and pharmacodynamics studies play a crucial role in understanding how drugs interact with the body over time, enabling the development of tailored treatment regimens that optimize efficacy and minimize adverse effects. The demand for such precision in drug development and therapeutic strategies is a key factor propelling the growth of the pharmacokinetics and pharmacodynamics market in the region. For instance, as per the National Cancer Institute, an estimated 1,806,590 new cases of cancer were diagnosed in the US in 2020. Similarly, according to the US Department of Health and Human Services, the prevalence of cancer in the US is 439.2 per 100,000 men and women.
Advancements in technology and analytical techniques are pivotal drivers propelling the North America pharmacokinetics and pharmacodynamics market. The continual evolution of mass spectrometry has revolutionized pharmacokinetics and pharmacodynamics studies, allowing for highly sensitive and specific measurements of drug concentrations and metabolites. The precision offered by modern mass spectrometric techniques contributes to accurate and reliable data, critical for making informed decisions in drug development. Integration of bioinformatics tools into pharmacokinetics and pharmacodynamics studies enhances the analysis of large datasets, facilitating the identification of biomarkers and predicting drug responses. Systems biology approaches provide a holistic understanding by integrating computational models and experimental data, capturing the complexity of drug responses at a systems level.
Pharmacokinetics and Pharmacodynamics Market Segment Insights
Pharmacokinetics and Pharmacodynamics Service Type Insights
Based on service type, the North America pharmacokinetics and pharmacodynamics market has been segmented into pharmacokinetic services, and pharmacodynamic services. The pharmacokinetic services segment is further segmented into drug absorption studies, drug distribution studies, drug metabolism studies, drug excretion studies, and others. pharmacodynamic services further segmented into receptor binding studies, biomarker analysis, and others. The Pharmacodynamic Services segment held the largest market in 2022 and Pharmacokinetic Services is the fastest growing segment during the forecast period.
Pharmacokinetics and Pharmacodynamics Drug Type Insights
Based on drug type, the North America pharmacokinetics and pharmacodynamics market has been segmented into small molecules and large molecules. The Small Molecules segment held the largest market in 2022 and Large Molecules is the fastest growing segment during the forecast period.
Pharmacokinetics and Pharmacodynamics Therapeutic Area Insights
Based on therapeutic area, the North America pharmacokinetics and pharmacodynamics market has been segmented into oncology, cardiovascular, infectious disease, neurology, immunology, and others. The Oncology segment held the largest market in 2022 and Infectious Diseases is the fastest growing segment during the forecast period.
Pharmacokinetics and Pharmacodynamics End User Insights
Based on end user, the North America pharmacokinetics and pharmacodynamics market has been segmented into pharmaceutical and biotechnology companies, academic and research institutions, and others. The Pharmaceutical and Biotechnology Companies segment held the largest market in 2022 and Academic and Research Institutions is the fastest growing segment during the forecast period.
FIGURE 2: NORTH AMERICA PHARMACOKINETICS AND PHARMACODYNAMICS MARKET, BY END USER, 2022 & 2032 (USD BILLION)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Pharmacokinetics and Pharmacodynamics Regional Insights
The North America pharmacokinetics and pharmacodynamics market is segmented into the US and Canada. The US held the largest market share of 82.34% based on region and Canada is anticipated to dominate the overall pharmacokinetics and pharmacodynamics market during the forecast period.
Further, the major countries studied are the US and Canada.
FIGURE 3: NORTH AMERICA PHARMACOKINETICS AND PHARMACODYNAMICS MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Pharmacokinetics and Pharmacodynamics Key Market Players & Competitive Insights
Major market players are spending a lot of money on R&D to increase their products, which will help the Pharmacokinetics and Pharmacodynamics Market grow even more. Market participants are also taking a range of strategic initiatives to increase their worldwide footprint, including new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the Pharmacokinetics and Pharmacodynamics industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.
Creative Bioarray is an innovative biotechnology company involved in the development and manufacturing of high-quality normal human and animal cells, cell culture medium and reagents, FISH probes, tissue arrays, microorganisms, and equipment for various applications. The company has a strong customer base in many industries such as pharmaceutical, biotechnology, agricultural, and diagnostic industries. Additionally, it provides solutions for reference and testing laboratories, academic institutions, government agencies, and private foundations. It has a strong network of distributors that is present in all the major markets, including the Americas, Europe, and Asia-Pacific. Also, the company has offices in Europe and the US.
Key Companies in the Pharmacokinetics and Pharmacodynamics Market include
Pharmacokinetics and Pharmacodynamics Market Segmentation
Pharmacokinetics and Pharmacodynamics Service Type Outlook
- Pharmacokinetic Services
- Drug Absorption Studies
- Drug Distribution Studies
- Drug Metabolism Studies
- Drug Excretion Studies
- Others
- Pharmacodynamic Services
- Receptor Binding Studies
- Biomarker Analysis
- Others
Pharmacokinetics and Pharmacodynamics Drug Type Outlook
- Small Molecules
- Large Molecules
Pharmacokinetics and Pharmacodynamics Therapeutic Area Outlook
- Oncology
- Cardiovascular
- Infectious Disease
- Neurology
- Immunology
- Others
Pharmacokinetics and Pharmacodynamics End User Outlook
- Pharmaceutical And Biotechnology Companies
- Academic And Research Institutions
- Others
Pharmacokinetics and Pharmacodynamics Region Outlook
| Report Attribute/Metric |
Details |
| Market Size 2022 |
USD 0.6 billion |
| Market Size 2023 |
USD 0.7 billion |
| Market Size 2032 |
USD 1.3 billion |
| Compound Annual Growth Rate (CAGR) |
7.09% (2023-2032) |
| Base Year |
2022 |
| Forecast Period |
2023-2032 |
| Historical Data |
2019 & 2020 |
| Forecast Units |
Value (USD Billion) |
| Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
service type, drug type, therapeutic area, end user, and country |
| Geographies Covered |
North America |
| Countries Covered |
US and Canada |
| Key Companies Profiled |
LGC Limited, Eurofins Scientific, Creative Biolabs, Creative Bioarray, Quanticate , Pacific BioLabs, Inc., Allucent, Charles River Laboratories, Evotec AG, SGS Société Générale de Surveillance SA. |
| Key Market Opportunities |
·      Growing popularity of personalized medicine |
| Key Market Drivers |
·      Increasing prevalence of chronic diseases ·      Advancements in technology and analytical techniques ·      Strong healthcare infrastructure |
Frequently Asked Questions (FAQ) :
The North America pharmacokinetics and pharmacodynamics market is anticipated to reach 1.3 billion by 2032 at a CAGR of 7.09% during the forecast period of 2023-2032.
The US held 82.34% share of the Pharmacokinetics and Pharmacodynamics Market in 2022.
The North America pharmacokinetics and pharmacodynamics market is expected to grow at 7.09% CAGR during the forecast period from 2023 to 2032.
The US region market held the largest market share in the North America pharmacokinetics and pharmacodynamics market.
